biomedicina slovenica


"Glioblastom" : 148

  1. Jovchevska Ivana; Zottel Alja; Šamec Neja; Mlakar Jernej; Muyldermans Serge; Buzdin Anton A.; Komel Radovan
    Combination of nanobody proteomics and OncoFinder bioinformatics in glioblastoma research and targeting
    2018
  2. Zottel Alja; Šamec Neja; Vidak Marko; Jovchevska Ivana
    From basic glioblastoma proteomics to promising diagnostic and therapeutic tools
    2018
  3. Šamec Neja; Komel Radovan; Čurin-Šerbec Vladka; Veranič Peter; Kos Janko
    Uporabnost nano-protiteles pri razvoju ciljanega zdravljenja glioblastoma
    [Implementation of nanobodies for the design of glioblastoma targeting therapy]
    2018
  4. Smrdel Uroš; Skoblar Vidmar Marija; Smrdel Aleš
    Glioblastoma in patients over 70 years of age
    2018
  5. Vidak Marko; Jovchevska Ivana; Šamec Neja; Zottel Alja; Liović Mirjana; Rozman Damjana; Džeroski Sašo; Juvan Peter; Komel Radovan
    Meta-analysis and experimental validation identified FREM2 and SPRY1 as new glioblastoma marker candidates
    2018
  6. Jovchevska Ivana
    Sequencing the next generation of glioblastomas
    2018
  7. Zupanec Neja; Jovchevska Ivana; Stojan Jure; Zottel Alja; Liović Mirjana; Myers Michael P.; Muyldermans Serge; Šribar Jernej; Križaj Igor; Komel Radovan
    Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting
    2018
  8. Georgakis Marios K.; Papathoma Paraskevi; Ryzhov Anton; Eser Sultan; Taraszkiewicz Łukasz; Sekerija Mario; Žagar Tina; Antunes Luis; Zborovskaya Anna A.; Bastos Joana
    Malignant central nervous system tumors among adolescents and young adults (15-39 years old) in 14 Southern-Eastern European registries and the US Surveillance, Epidemiology, and End Results program
    2017
  9. Komel Radovan
    Novel approaches in looking for glioblastoma - specific protein markers, and targeting
    2017
  10. Vidak Marko; Liović Mirjana; Jovchevska Ivana; Rozman Damjana; Džeroski Sašo; Komel Radovan
    Bioinformatic identification and experimental validation of new glioblastoma stem cell marker candidates
    2017
  11. Zottel Alja; Zupanec Neja; Jovchevska Ivana; Šribar Jernej; Križaj Igor; Zadravec-Zaletel Lorna; Komel Radovan
    Evaluation of nanobodies against potential glioblastoma biomarkers
    2017
  12. Breznik Barbara
    Niše tumorskih matičnih celic kot obetavne terapevtske tarče
    2017
  13. Jovchevska Ivana; Zupanec Neja; Urlep Žiga; Vranič Andrej; Matos Boštjan; Limbäck-Stokin Clara; Muyldermans Serge; Myers Michael P.; Buzdin Anton A.; Petrov Ivan; Komel Radovan
    Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates
    2017
  14. Vidak Marko; Liović Mirjana; Džeroski Sašo; Rozman Damjana; Komel Radovan
    Discovery of new glioblastoma stem cell marker candidates by analyzing mRNA microarray data from NCBI GEO database
    2017
  15. Zupanec Neja; Jovchevska Ivana; Zottel Alja; Liović Mirjana; Myers Michael P.; Podergajs Neža; Muyldermans Serge; Komel Radovan
    Identification of an anti-T nanobody in VHH library and its cytotoxic effect on glioblastoma cells
    2017
  16. Smrdel Uroš; Popović Mara; Zwitter Matjaž; Boštjančič Emanuela; Zupan Andrej; Kovač Viljem; Glavač Damjan; Bokal Drago; Jerebic Janja
    Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor
    2016
  17. Vidak Marko; Rozman Damjana; Liović Mirjana; Komel Radovan
    Search of new glioblastoma stem cell markers by comparing microarrays data from the NCBI geo database, and experimental validation of those markers in glioma cell lines
    2016
  18. Zottel Alja; Jovchevska Ivana; Zupanec Neja; Komel Radovan
    Glioblastoma multiforme and nanobodies
    2016
  19. Komel Radovan
    Functional analysis of proteomic biomarkers and targeting glioblastoma stem cells
    2016
  20. Jovchevska Ivana; Zupanec Neja; Urlep Žiga; Vranič Andrej; Matos Boštjan; Limbäck-Stokin Clara; Muyldermans Serge; Myres Michael P.; Buzdin Anton A.; Petrov Ivan; Komel Radovan
    Nanobody-based approach for the selection of novel differentially expressed proteins in glioblastoma multiforme and their potential use as biomarkers for class prediction
    2016
  21. Verbovšek Urška; Lah Turnšek Tamara; Noorden Cornelis J. F. van
    Cathepsin K as a potential tumor marker in glioblastoma multiforme
    2016
  22. Vidak Marko; Rozman Damjana; Liović Mirjana; Komel Radovan
    Search of new glioblastoma stem cell markers by analysis of NCBI GEO datasets, and experimental validation of those markers in glioma cell lines
    2016
  23. Komel Radovan
    Potential human glioblastoma cancer markers identified with nanobody-based reverse proteomic approach
    2016
  24. Jovchevska Ivana
    Exploiting nanobodies in the search for protein markers of glioblastoma multiforms
    2015
  25. Vittori Miloš; Breznik Barbara; Gredar Tajda; Hrovat Katja; Bizjak-Mali Lilijana; Lah Turnšek Tamara
    Imaging of human glioblastoma cells and their interactions with mesenchymal stem cells in the zebrafish (Danio rerio) embryonic brain
    2016
  26. Bisdas Sotirios; Smrdel Uroš; Bajrović Fajko; Šurlan Popović Katarina
    Assessment of progression-free-survival in glioblastomas by intratreatment dynamic contrast-enhanced MRI
    2016
  27. Motaln Helena; Schuchhardt Johannes; Stec Karol; Breznik Barbara; Ulrich Henning; Lah Turnšek Tamara
    Paradoxical role of mesenchymal stem cells in the glioblastoma microenvironment
    2014
  28. Mesti Tanja; Ocvirk Janja
    Evaluation of the glioblastoma cell lines response to arsenic trioxide (As [sub] 2O [sub] 3) and bevacizumab according to the IDH1 mutation status
    [Odgovor glioblastomskih celičnih linij na arzenov trioksid (As [spodaj] 2O [spodaj] 3) in bevacizumab glede na prisotnost IDH1 mutacije]
    2015
  29. Panjan Peter; Štrukelj Borut
    Razvoj genskega zdravljenja pri glioblastomu
    [Development of gene therapy for glioblastoma]
    2014
  30. Matos Boštjan; Boštjančič Emanuela; Popović Mara; Glavač Damjan
    Dynamic of expression of eleven micrornas in recurrent glioblastoma before and after treatment with radiotherapy and chemotherapy
    2015
  31. Vidak Marko; Rozman Damjana; Komel Radovan
    Effects of flavonoids from food and dietary supplements on glial and glioblastoma multiforme cells
    2015
  32. Glavač Damjan
    The predictive value of MGMT promotor methylation in glioblastoma patients
    2015
  33. Boštjančič Emanuela; Matos Boštjan; Popović Mara
    microRNA signatures in operable recurrent glioblastoma before and after treatment
    2015
  34. Smrdel Uroš; Popović Mara; Zwitter Matjaž; Boštjančič Emanuela; Zupan Andrej; Kovač Viljem; Glavač Damjan; Bokal Drago; Jerebic Janja
    Long-term survival in glioblastoma
    2015
  35. Vidak Marko; Jovčevska Ivana; Zupanec Neja; Komel Radovan
    Analysis of communication networks of glioblastoma stem cell markers
    2015
  36. Zupanec Neja; Jovčevska Ivana; Liović Mirjana; Komel Radovan
    Localization and cytotoxicity of nanobodies directed against glioblastoma multiforme biomarkers
    2015
  37. Mihalic Filip; Zupanec Neja; Jovčevska Ivana; Komel Radovan; Liović Mirjana
    Glioblastoma specific nanobodies
    2015
  38. Komel Radovan
    TRIM28 and beta-actin as potential biomarkers for glioblastoma targeting
    2015
  39. Vidak Marko; Jovčevska Ivana; Zupanec Neja; Komel Radovan
    Cell communication network analysis of glioblastoma stem cell marker candidates [beta]-actin, CD9, FTL, S100A9 and TRIM28
    2015
  40. Verbovšek Urška; Motaln Helena; Rotter Ana; Atai Nadia A.; Gruden Kristina; Noorden Cornelis J. F. van; Lah Turnšek Tamara
    Expression analysis of all protease genes reveals cathepsin K to be overexpressed in glioblastoma
    2014
  41. Verbovšek Urška; Motaln Helena; Levičar Nataša; Rotter Ana; Lah Turnšek Tamara
    The duality of stem cells
    2013
  42. Komel Radovan
    Looking for proteomic biomarkers at glioblastoma multiforme
    2015
  43. Strojnik Tadej; Kavalar Rajko
    Experimental model and immunohistochemical analyses of U87 human glioblastoma cell xenografts in a chick embryo model
    2009
  44. Mesti Tanja; Ebert Moltara Maja; Boc Marko; Reberšek Martina; Ocvirk Janja
    Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience
    2015
  45. Smrdel Uroš; Šečerov Ermenc Ajra
    Treatment and survival of glioblastoma patients in Slovenia, 1997-2006
    2008
  46. Komel Radovan; Jovčevska Ivana; Zupanec Neja; Kočevar Nina; Muyldermans Serge
    Can we find specific glioblastoma stem cell markers with a proteomic approach?
    2014
  47. Popović Mara
    Glioblastoma
    [(Glioblastoma)]
    2013
  48. Jovčevska Ivana; Zupanec Neja; Kočevar Nina; Cesselli Daniela; Podergajs Neža; Limbäck-Stokin Clara; Myers Michael P.; Muyldermans Serge; Hassanzadeh Ghassabeh Gholamreza; Motaln Helena; Ruaro Maria Elisabetta; Bourkoula Evgenia; Lah Turnšek Tamara; Komel Radovan
    TRIM28 and [beta]-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers
    2014
  49. Vittori Miloš; Podergajs Neža; Motaln Helena; Lah Turnšek Tamara
    Orthotopic xenotransplantation of human cancer cells into zebrafish embryos for the in vivo study of glioblastoma
    2014
  50. Breznik Barbara; Motaln Helena; Golob Monika; Lah Turnšek Tamara
    Proteolytic cascades in glioblastoma and mesenhymal stem cells direct cross-talk
    2014
  51. Zupančič Klemen; Blejec Andrej; Herman Ana; Veber Matija; Verbovšek Urška; Koršič Marjan; Knežević Miomir; Rožman Primož; Lah Turnšek Tamara; Gruden Kristina; Motaln Helena
    Identification of plasma biomarker candidates in glioblastoma using an antibody-array-based proteomic approach
    [[Ugotavljanje možnih plazemskih bioloških označevalcev pri glioblastomu z uporabo proteomske tehnike mikromrež s protitelesi]]
    2014
  52. Vittori Miloš; Podergajs Neža; Motaln Helena; Breznik Barbara; Lah Turnšek Tamara
    The zebrafish embryonic brain as the area of tumour cell xenotransplantation for glioblastoma progression studies
    2014
  53. Mesti Tanja; Savarin Philippe; Triba Mohamed N.; Le Moyec Laurence; Ocvirk Tanja; Banissi Claire; Carpentier Antoine F.
    Metabolic impact of anti-angiogenic agents on U87 glioma cells
    2014
  54. Primon Monika; Lah Turnšek Tamara
    Učinek arzenovega trioksida in utišanja katepsina L ter vpliv mezenhimskih matičnih celic na celice glioblastoma
    2014
  55. Smrdel Uroš; Kovač Viljem; Popović Mara; Zwitter Matjaž
    Glioblastoma patients in Slovenia from 1997 to 2008
    2014
  56. Podergajs Neža; Lah Turnšek Tamara
    Vloga signalnih poti EGFR in FGFR ter novih označevalcev pri glioblastomskih matičnih celicah
    2013
  57. Strojnik Tadej; Šmigoc Tomaž; Lah Turnšek Tamara
    Prognostic value of erythrocyte sedimentation rate and C-reactive protein in the blood of patients with glioma
    2014
  58. Podergajs Neža; Brekka Narve; Radlwimmer Bernhard; Herold-Mende Christel; Talasila Krishna M.; Tiemann Katja; Rajčević Uroš; Lah Turnšek Tamara; Bjerkvig Rolf; Miletic Hrvoje
    Expansive growth of two glioblastoma stem-like cell lines is mediated by bFGF and not by EGF
    2013
  59. Podergajs Neža; Rajčević Uroš; Verbovšek Urška; Motaln Helena; Niclou Simone P.; Jimenez Connie R.; Herold-Mende Christel; Lah Turnšek Tamara
    CD9 is a potential stem cell marker of glioblastoma stem-like cells
    2013
  60. Kočevar Nina; Jovčevska Ivana; Cesselli Daniela; Kastelic Damjana; Muyldermans Serge; Komel Radovan
    Llama heavy chain antibodies as means to identify glioblastoma biomarkers
    2013
  61. Verbovšek Urška; Motaln Helena; Rotter Ana; Gruden Kristina; Noorden Cornelis J. F. van; Lah Turnšek Tamara
    Cathespin K is upregulated in the brain tumour glioblastoma multiforme
    2013
  62. Jovčevska Ivana; Kočevar Nina; Komel Radovan
    Glioma and glioblastoma how much do we (not) know? (Review)
    2013
  63. Verbovšek Urška; Motaln Helena; Rotter Ana; Gruden Kristina; Noorden Cornelis J. F. van
    Cathepsin K is upregulated in the brain tumour glioblastoma multiforme
    2013
  64. Petersen Kjell; Rajčević Uroš; Rahim Siti Aminah Abdul; Jonassen Inge; Kalland Karl-Henning; Jimenez Connie R.; Bjerkvig Rolf; Niclou Simone P.
    Gene set based integrated data analysis reveals phenotypic differences in a brain cancer model
    2013
  65. Komel Radovan; Jovchevska Ivana; Kočevar Nina; Muyldermans Serge; Kastelic Damjana; Cesselli Daniela
    Llama heavy-chain antibodies in search for glioblastoma stem cell biomarkers with diagnostic/prognostic and therapeutic values
    2013
  66. Obrez Mateja; Motaln Helena; Tajnšek Urška; Lah Turnšek Tamara
    Vloga matičnih celic pri napredovanju in zdravljenju glioma
    [#The #role of stem cells in glioma progression and therapy]
    2013
  67. Tajnšek Urška; Motaln Helena; Rotter Ana; Gruden Kristina; Van Noorden Cornelis JF; Lah Turnšek Tamara
    Glioblastoma transcriptomics
    2013
  68. Primon Monika; Huszthy Peter C.; Motaln Helena; Talasila Krishna M.; Bjerkvig Rolf; Lah Turnšek Tamara
    Cathepsin L silencing affects arsenic trioxide - mediated cytotoxicity and apoptosis in U87MG spheroids
    2013
  69. Podergajs Neža; Rajčević Uroš; Tajnšek Urška; Motaln Helena; Niclou Simone P.; Jimenez Connie R.; Herold Mende Christel; Miletic Hrvoje; Bjerkvig Rolf; Lah Turnšek Tamara
    Transmembrane protein CD9 is a potential selective stem cell marker of glioblastoma stem-like cells
    2013
  70. Obrez Mateja; Motaln Helena; Gruden Kristina; Jürchott Kathrin; Lah Turnšek Tamara
    BDKRB1 expression differentially changes in GBM and MSC(in) direct co-cultures
    2013
  71. Kološa Katja; Motaln Helena; Lah Turnšek Tamara
    Mesenchymal stem cells reduce the stemness of glioblastoma stem cells
    2013
  72. Popović Mara
    Glioblastom
    [(Glioblastoma)]
    2012
  73. Lah-Turnšek Tamara; Motaln Helena; Gruden Kristina; Hren Matjaž; Rotter Ana; Schichor Christian
    Cancer associated stem cells in glioblastoma and their clinical relevance
    2012
  74. Šimenc Janez; Lipnik-Štangelj Metoda
    Staurosporine induces different cell death forms in cultured rat astrocytes
    2012
  75. Vrabec Matej; Van Cauter Sofie; Himmelreich Uwe; Van Gool Stefaan W; Sunaert Stefan; De Vleeschouwer Steven; Šuput Dušan; Demaerel Philippe
    MR perfusion and diffusion imaging in the follow-up of recurrent glioblastoma treated with dendritic cell immunotherapy: a pilot study
    2011
  76. Strojnik Tadej
    Prognostic significance of immunohistochemical markers in glioma patients
    2011
  77. Chen Clark C
    Advances in the biology, imaging and therapies for glioblastoma
    2011
  78. Tezcan Yilmaz; Koc Mehmet
    3-D conformal radiotherapy with concomitant and adjuvant temozolomide for patients with glioblastoma multiforme and evaluation of prognostic factors
    [3-D konformno obsevanje s hkratnim in dodatnim zdravljenjem s temozolomidom pri bolnikih z multiformnim glioblastomom in določitev napovednih dejavnikov]
    2011
  79. Zupančič K; Rajčević U; Hren M; Herman A; Štabuc B; Ravnikar M; Knežević M; Rožman P; Jeras M; Gruden K
    Glioblastoma analysis using systems biology approaches
    2011
  80. Motaln H; Gruden K; Hren M; Primon M; Schichor C; Lah TT
    Human mesenchymal stem cells exploit the immune response mediating chemokines to impact the phenotype of glioblastoma
    2011
  81. Motaln Helena; Gruden Kristina; Hren Matjaž; Schichor Cristian; Primon Monika; Lah Tamara T
    Human mesenchymal stem cells impact glioblastoma cells
    2011
  82. Ardebili Seyed Y; Zajc Irena; Gole Boris; Campos Benito; Herold-Mende Christel; Drmota Sara; Lah Tamara T
    CD133/prominin1 is prognostic for GBM patient's survival, but inversely correlated with cysteine cathepsine' expression in gliobastoma derived spheroids
    [CD133/prominin1 je prognostičen za preživetje bolnikov z glioblastoma, vendar obratno korelira z izražanjem cisteinskih katepsinov]
    2011
  83. Strojnik Tadej; Kavalar Rajko; Barone Tara A.; Plunkett Robert J.
    Experimental model and immunohistochemical comparison of U87 human glioblastoma cell xenografts on the chicken chorioallantoic membrane and in rat brains
    2010
  84. Kenig S; Majdič T; Duran-Alonso MB; Lah T
    Endothelial cells increase invasiveness of glioblastoma cells and protect them from apoptosis
    2010
  85. Lah-Turnšek Tamara
    Tumour microenvironment in glioblastoma and the role of stem cells
    2010
  86. Pucer Anja
    Delovanje arzenovega trioksida na človeške glioblastomske celice ter vloga cisteinskih katepsinov: doktorska disertacija
    2010
  87. Gole Boris
    Izražanje cisteinskih katepsinov in njihovih endogenih inhibitorjev v glioblastomih in njihovih izvornih celicah
    2009
  88. Kenig Saša; Duran-Alonso Maria-Beatriz; Mueller Margareta M; Lah-Turnšek Tamara
    Endothelial cells increase invasiveness of glioblastoma cells via SDF-1, cathepsin B and MMP9
    2010
  89. Zajc Irena; Filipič Metka; Lah-Turnšek Tamara
    Xanthohumol induces differential cytotoxicity and triggers apoptotic pathways in normal astrocytes and in glioblastoma cells
    2010
  90. Rajčević Uroš; Bougnaud Sebastien
    iTRAQ based proteomic profiling reveals increased metabolic activity and cellular crosstalk in angiogenic compared to invasive glioblastoma phenotype
    2009
  91. Lah Tamara
    Approaching complexity by complexity: to reveal glioblastoma heterogeneity by systems biology tools
    2009
  92. Pucer Anja; Castino Roberta; Isidoro Ciro; Lah Tamara T
    Involvement of lysosomal cysteine cathepsins B and L in the cytotoxic mechanism of As2O3 in glioblastoma cells
    2009
  93. Volavšek Metka; Lamovec Janez; Popović Mara
    Extraneural metastases of anaplastic oligodendroglial tumors
    2009
  94. Pucer A; Kenig S; Duran-Alonso MB; Lah TT
    Arsenic trioxide and the lysosomal cysteine cathepsins in cell death of U87 glioblastoma cells
    2009
  95. Terzis A Jorge A; Niclou Simone P; Rajčević Uroš; Danzeisen Claude; Bjerkvig Rolf
    Cell therapies for glioblastoma
    2006
  96. Rajčević Uroš; Knol Jaco C; Loos Maarten; Enger Per Oyvind; Wang Jian; Bjerkvig Rolf; Petersen Kjell; Jimenez Connie R; Niclou Simone P
    Addressing the angiogenic switch by studying tumor-host interactions in an animal model of glioblastoma multiforme
    2008
  97. Rajčević Uroš; Knol Jaco C; Loos Maarten; Petersen Kjell; Bjerkvig Rolf; Jimenez Connie R; Niclou Simone P
    Addressing the Angiogenic Switch by Studying Tumor-Host Interactions in an Animal Model of Glioblastoma Multiforme
    2008
  98. Knecht W; Rozpedowska E; Le Breton C; Willer M; Gojkovic Z; Sandrini MP; Joergensen T; Hasholt L; Munch-Petersen B; Piškur J
    Drosophila deoxyribonucleoside kinase mutants with enhanced ability to phosphorylate purine analogs
    2007
  99. Strojnik Tadej; Gornik-Kramberger Kristina
    Stereotaktična biopsija možganskih tumorjev - mariborske izkušnje z uporabo stereotaktičnega sistema MHT
    [Stereotactic biopsy of brain tumours - Maribor experience with MHT stereotaxy system]
    2008
  100. Pucer Anja; Kenig Saša; Duran-Alonso Maria Beatriz; Šlejkovec Zdenka; Lah-Turnšek Tamara
    Arsenite and the lysosomal cysteine cathepsins in cell death of U87 glioblastoma cells
    2008

1 101  



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics